⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AGEN News
Agenus Inc.
Ligand Reports First Quarter 2026 Financial Results
globenewswire.com
LGND
XOMA
MRK
SNDX
AGEN
Agenus to Provide First Quarter 2026 Financial Report and Corporate Update
businesswire.com
AGEN
Agendia to Present New FLEX Study Data at ASBrS 2026 Confirming the Consistent Performance of MammaPrint + BluePrint Across Diverse Racial Groups in Genomically Basal-Type Breast Cancer
businesswire.com
AGEN
アジーナス、BOT+BALアクセスプログラムの独占的グローバルパートナーにBAP Pharmaを指名
businesswire.com
AGEN
アジーナス、BOT+BALアクセスプログラムの独占的グローバルパートナーにBAP Pharmaを指名
businesswire.com
AGEN
Riassunto: Agenus nomina BAP Pharma partner esclusivo globale per i programmi di accesso a BOT+BAL
businesswire.com
AGEN
Agenus designa a BAP Pharma como socio global exclusivo para BOT+BAL
businesswire.com
AGEN
Agenus nomeia a BAP Pharma como parceira global exclusiva para os programas de acesso BOT+BAL
businesswire.com
AGEN
Agenus designa a BAP Pharma como socio global exclusivo para BOT+BAL
businesswire.com
AGEN
Agenus ernennt BAP Pharma zum exklusiven globalen Partner für die BOT+BAL-Zugangsprogramme
businesswire.com
AGEN